55507-79-4

Downstream Products

• 113239-50-2 4-(2,3-dichloro-4-valerylphenoxy)butyric acid 
• 113262-79-6 4-<2,3-dichloro-4-(2-methylenevaleryl)phenoxy>butyric acid 
• 113239-55-7 1-(2,3-dichloro-4-valerylphenoxy)cyclobutane-1-carboxylic acid 
• 113239-20-6 1-<2,3-dichloro-4-(2-methylenevaleryl)phenoxy>cyclobutane-1-carboxylic acid 

Relevant academic research and scientific papers

[1-Oxo-2-halo(or hydrogen) indanyloxy]-alkanoic acid

[1-Oxo-2-halo(or hydrogen)indanyloxy(or thio)]-alkanoic acid products and salts, esters and amide derivatives where the indanyl ring may be further substituted with from 2 to 5 nuclear substituents. The [1-oxo-2-haloindanyloxy-(or thio)]alkanoic acids are prepared (1) via the halogenation of a [1-oxoindanyloxy(or thio)]alkanoic acid or (2) via the addition of halogen to a [1-oxoindenyloxy(or thio)]-alkanoic acid. The [1-oxoindanyloxy(or thio)]alkanoic acids are prepared (1) via cyclialkylation of a (2-alkylideneacyl)-phenoxy(or thio)alkanoic acid or (2) via etherification of a hydroxy(or mercapto)-2-alkyl-1-indanone. The [1-oxo-2-halo(or hydrogen)indanyloxy(or thio)]alkanoic acids are diuretics and saluretics. In addition, some of these compounds are also able to maintain the uric acid concentration in the body at pretreatment level or to cause a decrease in uric acid concentration.